Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $1 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $1 | $142 | $128 | $1 |
| % Growth | -99.3% | 10.4% | 11,804.8% | – |
| Gross Profit | $1 | $79 | $1 | $1 |
| % Margin | 58.5% | 55.7% | 0.4% | 58.3% |
| EBITDA | $0 | $24 | $0 | $17 |
| % Margin | 22.5% | 17.2% | 0.1% | 1,604.6% |
| Net Income | $0 | $14 | $0 | $10 |
| % Margin | 13.9% | 9.9% | 0.1% | 895.9% |
| EPS Diluted | 0.48 | 0.32 | 0.28 | 0.27 |
| % Growth | 50% | 14.3% | 3.7% | – |
| Operating Cash Flow | $0 | $18 | $0 | $0 |
| Capital Expenditures | -$0 | -$13 | -$0 | -$0 |
| Free Cash Flow | $0 | $5 | $0 | $0 |